Related content

Tolerability of adjuvant chemotherapy with S-1 after curative resection in patients with stage II/III gastric cancer

By                      

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 1135-1139

Spandidos Publications

Access to resources Recommend Favorite

Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy

By Fujitani Kazumasa   Tamura Shigeyuki   Kimura Yutaka   Tsuji Takeshi   Matsuyama Jin   Iijima Shohei   Imamura Hiroshi   Inoue Kentaro   Kobayashi Kenji   Kurokawa Yukinori   Shimokawa Toshio   Tsujinaka Toshimasa   Furukawa Hiroshi  

Gastric Cancer, Vol. 17, Iss. 2, 2014-04 ,pp. : 348-353

Springer Publishing Company

Access to resources Recommend Favorite

Survival and prognosticators of gastric cancer that recurs after adjuvant chemotherapy with S-1

By Aoyama Toru  

Gastric Cancer, Vol. 14, Iss. 2, 2011-06 ,pp. : 150-154

Springer Publishing Company

Access to resources Recommend Favorite

Second-line chemotherapy with irinotecan plus cisplatin after the failure of S-1 monotherapy for advanced gastric cancer

By Takahari Daisuke   Shimada Yasuhiro   Takeshita Shigeyuki   Nishitani Hitoshi   Takashima Atsuo   Okita Natsuko   Hirashima Yoshinori   Kato Ken   Hamaguchi Tetsuya   Yamada Yasuhide   Shirao Kuniaki  

Gastric Cancer, Vol. 13, Iss. 3, 2010-08 ,pp. : 186-190

Springer Publishing Company

Access to resources Recommend Favorite

Three-weekly S-1 plus cisplatin chemotherapy as first-line treatment for advanced gastric cancer

By Choi In   Lee Keun-Wook   Kim Ki   Kim Yu   Kim Jee   Lee Jong  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 992-997

Humana Press, Inc

Access to resources Recommend Favorite